BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 17373923)

  • 1. Prognostic value of hepatic venous pressure gradient for in-hospital mortality of patients with severe acute alcoholic hepatitis.
    Rincon D; Lo Iacono O; Ripoll C; Gomez-Camarero J; Salcedo M; Catalina MV; Hernando A; Clemente G; Matilla A; Nuñez O; Bañares R
    Aliment Pharmacol Ther; 2007 Apr; 25(7):841-8. PubMed ID: 17373923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era.
    Ripoll C; Bañares R; Rincón D; Catalina MV; Lo Iacono O; Salcedo M; Clemente G; Núñez O; Matilla A; Molinero LM
    Hepatology; 2005 Oct; 42(4):793-801. PubMed ID: 16175621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
    Kim MY; Baik SK; Suk KT; Yea CJ; Lee IY; Kim JW; Cha SH; Kim YJ; Um SH; Han KH
    Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the Model for End-stage Liver Disease and hepatic venous pressure gradient for predicting survival in patients with decompensated liver cirrhosis].
    Lee SH; Park SH; Kim GW; Lee WJ; Hong WK; Ryu MS; Park KT; Lee MY; Lee CW; Kim JH; Kim YM; Kim SJ; Baik GH; Kim JB; Kim DJ
    Korean J Hepatol; 2009 Sep; 15(3):350-6. PubMed ID: 19783884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of the hepatic venous pressure gradient to monitor drug therapy for portal hypertension: a meta-analysis.
    Albillos A; Bañares R; González M; Ripoll C; Gonzalez R; Catalina MV; Molinero LM
    Am J Gastroenterol; 2007 May; 102(5):1116-26. PubMed ID: 17391317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
    Wang YW; Huo TI; Yang YY; Hou MC; Lee PC; Lin HC; Lee FY; Chi CW; Lee SD
    J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic venous pressure gradient does not correlate with the presence and the severity of portal hypertensive gastropathy in patients with liver cirrhosis.
    Bellis L; Nicodemo S; Galossi A; Guarisco R; Spilabotti L; Durola L; Dell'Unto O; Puoti C
    J Gastrointestin Liver Dis; 2007 Sep; 16(3):273-7. PubMed ID: 17925921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of hepatic venous pressure gradient and two models of end-stage liver disease for predicting the survival in patients with decompensated liver cirrhosis.
    Suk KT; Kim CH; Park SH; Sung HT; Choi JY; Han KH; Hong SH; Kim DY; Yoon JH; Kim YS; Baik GH; Kim JB; Kim DJ
    J Clin Gastroenterol; 2012; 46(10):880-6. PubMed ID: 22810110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis.
    Samonakis DN; Cholongitas E; Thalheimer U; Kalambokis G; Quaglia A; Triantos CK; Mela M; Manousou P; Senzolo M; Dhillon AP; Patch D; Burroughs AK
    Liver Transpl; 2007 Sep; 13(9):1305-11. PubMed ID: 17763383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver collagen proportionate area predicts decompensation in patients with recurrent hepatitis C virus cirrhosis after liver transplantation.
    Calvaruso V; Dhillon AP; Tsochatzis E; Manousou P; Grillo F; Germani G; Patch D; O'Beirne J; Burroughs AK
    J Gastroenterol Hepatol; 2012 Jul; 27(7):1227-32. PubMed ID: 22432427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hepatic hemodynamic study in the evaluation of patients with cirrhosis.
    Dittrich S; de Mattos AA; Becker M; Gonçaves DM; Cheinquer H
    Hepatogastroenterology; 2003; 50(54):2052-6. PubMed ID: 14700005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis.
    Nagula S; Jain D; Groszmann RJ; Garcia-Tsao G
    J Hepatol; 2006 Jan; 44(1):111-7. PubMed ID: 16274836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic venous pressure gradient as a predictor of fibrosis in chronic liver disease because of hepatitis B virus.
    Kumar M; Kumar A; Hissar S; Jain P; Rastogi A; Kumar D; Sakhuja P; Sarin SK
    Liver Int; 2008 May; 28(5):690-8. PubMed ID: 18433395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis.
    Sen S; Mookerjee RP; Cheshire LM; Davies NA; Williams R; Jalan R
    J Hepatol; 2005 Jul; 43(1):142-8. PubMed ID: 15878216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baroreceptor sensitivity and baroreceptor effectiveness index in cirrhosis: the relevance of hepatic venous pressure gradient.
    Genovesi S; Prata Pizzala DM; Pozzi M; Ratti L; Milanese M; Vincenti A; Stella A; Mancia G
    Liver Int; 2010 Feb; 30(2):232-9. PubMed ID: 19793198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? No.
    Thalheimer U; Bellis L; Puoti C; Burroughs AK
    Eur J Intern Med; 2011 Feb; 22(1):5-7. PubMed ID: 21238884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension.
    La Mura V; Abraldes JG; Raffa S; Retto O; Berzigotti A; García-Pagán JC; Bosch J
    J Hepatol; 2009 Aug; 51(2):279-87. PubMed ID: 19501930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension.
    Escorsell A; Bordas JM; Castañeda B; Llach J; García-Pagán JC; Rodés J; Bosch J
    Hepatology; 2000 May; 31(5):1061-7. PubMed ID: 10796880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension.
    La Mura V; Reverter JC; Flores-Arroyo A; Raffa S; Reverter E; Seijo S; Abraldes JG; Bosch J; García-Pagán JC
    Gut; 2011 Aug; 60(8):1133-8. PubMed ID: 21427197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.